Eyetale Max Eye Drops contain Sodium Hyaluronate (0.4% w/v), an ultra-high concentration ophthalmic lubricant formulated for severe and chronic dry eye conditions. It delivers maximum hydration, prolonged tear film stability, and superior ocular surface protection.
Sodium Hyaluronate functions by attracting and retaining moisture on the ocular surface, significantly reducing dryness, irritation, and foreign body sensation. Its enhanced viscosity ensures extended lubrication and reduced blink-related friction, even in extreme dryness.
Clinically, Eyetale Max Eye Drops are preferred for post-operative eye care, advanced ocular surface disorders, long screen exposure, and harsh environmental conditions, helping restore comfort and visual clarity.
From a business perspective, Eyetale Max Eye Drops strengthen the premium and advanced dry eye therapy segment, offering high prescription value, repeat demand, and strong profitability for PCD pharma franchise partners. Its clinical reliability and prescriber confidence make it a powerful portfolio-building product.